Lexology August 23, 2022
Hogan Lovells

A newly released audit by the Office of Inspector General (OIG) found that for clinical trials funded by the National Institutes of Health (NIH) for which responsible parties were required to submit results to ClinicalTrials.gov in 2019 or 2020, a majority did not have their results timely submitted. As a result, OIG has recommended that NIH take additional enforcement actions against responsible parties that fail to meet their clinical trial reporting requirements, and NIH has responded that it is enhancing its abilities to track ClinicalTrials.gov non-compliance for its studies.

Federal law requires responsible parties (typically clinical trial sponsors) to submit results for their studies registered on ClinicalTrials.gov, generally no later than one year after the study’s completion date. However, according...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, FDA, Govt Agencies, OIG, Survey / Study, Trends
Cutting and pasting (aka cloned) EHR portions can lead to false claims
HHS-OIG Highlights Anti-Fraud Safeguards for Patient Assistance Programs Backed Mainly by Drug Manufacturers
Improper Payments in Medicare and Medicaid: Who's at Fault?
Only 8% of Medicaid and 4% of Medicare Enrollees Received Behavioral Health Services
OIG Targets Home Health Improper Payments, EVV, Consumer-Directed Programs in Ongoing Watchdog Initiatives

Share This Article